-
BLSM share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of BLSM shares has decreased $0.13 since the market last closed. This is a 0.71% drop.
-
Opened at $18.58.
The stock opened $0.16 higher than its previous close.
Key terms
About BLSM
Blossomhill Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded on June 22, 2020 and is headquartered in San Diego, CA.
-
Market cap: $564.46M
A market capitalization between $300 million and $2 billion places BLSM in the small capitalization category.
Key terms
Smart score
Latest BLSM news
BLSM Financials
-
BLSM total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
BLSM net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
BLSM earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
BLSM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BLSM Competitors
-
How competitors are chosen
BLSM's competitors are included in the Health Technology sector and Pharmaceuticals: Major group
-
Market cap: $564.46M
A market capitalization between $300 million and $2 billion places BLSM in the small capitalization category.
Key terms
Latest investing news
-
Bond market takes a breather after surprise move by Treasury Department -
Global bond markets are getting hammered. Here’s why that could make your life more expensive -
‘Brazen act of self-dealing.’ Lawmakers, watchdogs alarmed after Trump regulators let Trump firm start a bank -
The S&P 500 is back at a record high and the Dow just hit 54,000
